# PI31: a regulator of proteasome adaptation to stress

> **NIH NIH R01** · UT SOUTHWESTERN MEDICAL CENTER · 2021 · $324,000

## Abstract

ABSTRACT
 Proteasome-catalyzed proteolysis is a central regulatory element of most essential eukaryotic
cellular processes. Proteasome function is regulated at many levels including the assembly of multiple
proteasome holoenzymes, alterations of the relative and absolute amount of holoenzymes, and direct
control of holoenzyme activity. Proteasome holoenzymes are composed of a protease core complex
(20S proteasome) interchangeably bound to any of multiple regulatory complexes. The goals of this
research are to discover the physiologic roles of PI31, the most poorly understood and least studied
proteasome regulator, and to determine the molecular and cellular basis of its function and regulation.
The project is based on the premise that PI31 mediates cellular changes in proteasome-dependent
protein degradation during cellular stress. We will test the general hypothesis that PI31 exerts
this role by regulating proteasome content, composition, and/or function in response to stress.
We also will test the hypothesis that PI31 action is regulated by reversible PI31 posttranslational
modifications cued by specific stress-induced signals. We will employ a complementary suite of
cellular and molecular approaches to define the mechanisms by which PI31 accomplishes its role,
the regulation of these mechanisms by PI31 posttranslational modifications, and the physiologic
significance of these effects.
 The pervasive role of proteasome-catalyzed protein degradation in normal cellular function
and regulation explains why many diseases are associated with abnormal proteasome function or
how diseased cells exploit normal proteasome action to their advantage. Such knowledge is the
foundation of current proteasome-based therapies to treat cancer. A deeper understanding of
normal proteasome function and regulation will significantly advance understanding of the
molecular basis of human diseases and provide new strategies for their treatment.

## Key facts

- **NIH application ID:** 10152660
- **Project number:** 5R01GM129088-03
- **Recipient organization:** UT SOUTHWESTERN MEDICAL CENTER
- **Principal Investigator:** George N. DeMartino
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $324,000
- **Award type:** 5
- **Project period:** 2019-08-01 → 2023-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10152660

## Citation

> US National Institutes of Health, RePORTER application 10152660, PI31: a regulator of proteasome adaptation to stress (5R01GM129088-03). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10152660. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*